NCT07400640 Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia
| NCT ID | NCT07400640 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Diskapi Teaching and Research Hospital |
| Condition | Postherpetic Neuralgia |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-06-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study aims to compare the effectiveness of ultrasound-guided erector spinae plane (ESP) block and transcutaneous radiofrequency (RF) treatment in patients with postherpetic neuralgia. Pain intensity and neuropathic pain characteristics will be evaluated using the Visual Analog Scale (VAS) and the Self-Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) score.
Eligibility Criteria
Inclusion Criteria: Diagnosis of postherpetic neuralgia involving cervical, thoracic, or lumbar regions Age between 18 and 80 years Persistent pain despite conservative treatment Baseline VAS score \> 5 Exclusion Criteria: Ophthalmic or extremity postherpetic neuralgia Allergy to local anesthetics Pregnancy Coagulopathy or use of antiplatelet therapy Cognitive impairment preventing informed consent
Contact & Investigator
AYSE BETUL ACAR
PRINCIPAL INVESTIGATOR
Diskapi TRH
Frequently Asked Questions
Who can join the NCT07400640 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Postherpetic Neuralgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07400640 currently recruiting?
Yes, NCT07400640 is actively recruiting participants. Contact the research team at betulbozann@gmail.com for enrollment information.
Where is the NCT07400640 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07400640 clinical trial?
NCT07400640 is sponsored by Diskapi Teaching and Research Hospital. The principal investigator is AYSE BETUL ACAR at Diskapi TRH. The trial plans to enroll 50 participants.